AI is the new tool of choice for battling cancer, and Andy Moye’s company is at the forefront on a mission to advance cancer detection and patient care and treatment by using cutting-edge artificial intelligence.

They are revolutionizing and accelerating the way we conquer this universal enemy.

Andy is CEO and Board Member at Paige AI, which is the only company that FDA approved to use AI in diagnosing cancer pathology.

This includes the U.S. launch of Paige Prostate Detect, the first and only AI-based pathology product to receive FDA marketing authorization for in vitro diagnostic (IVD) use in detecting cancer in prostate biopsies.

His involvement in pathology began around 2005 and he’s been at the forefront of the molecular diagnostics, biotechnology, and life sciences industries for nearly two decades, focusing on pathology, oncology, genomics, and precision medicine.

Before that, he served in the Navy for eight years flying P-3C aircraft.

LinkedIn Profile https://www.linkedin.com/in/andymoye/

Company Link: https://paige.ai/

What You’ll Discover in this Episode:

AI’s impact on the healthcare industry.

The two sides of AI that will have the biggest impact in the next three to five years.

Rampant physician burnout - How AI is addressing it.

What company leaders should be asking their health benefit providers.

The moment he realized he wanted to lead in healthcare.

The one skill that’s contributed most to his success.

A strategy that motivates your team.

Why an AI company prioritizes people first.

Are you trying to get your team to like you? Don’t!

What he learned from having one-on-one’s with 100 employees.

-----

Connect with the Host, #1 bestselling author Ben Fanning

Speaking and Training inquires

Subscribe to my Youtube channel

LinkedIn

Instagram

Twitter